Note: results can be filtered by year and/or keyword. To filter on year, select the appropriate year from the drop down menu. To filter on keyword, enter relevant term into open box, select appropriate keyword, and click "filter".
Statements, Speeches, Letters
Médecins Sans Frontières (MSF) has learnt that India's Intellectual Property Appellate Board (IPAB) in Chennai has postponed hearing the appeal by German pharmaceutical company Bayer over the granting of a compulsory licence to generic company Natco until Monday 3 September.
Last updated 21 August 2012
65th World Health Assembly; Agenda item 13.16 Disease eradication, prevention and control Intervention by Michelle Childs, Médecins Sans Frontières International Médecins Sans Frontières actively responds to, and advocates on, many different diseases under discussion today. These include:
Last updated 26 May 2012
65th World Health Assembly; Agenda item 13.12 Draft Global Vaccine Action Plan Intervention by Kate Elder, Médecins Sans Frontières International Médecins Sans Frontières welcomes the renewed focus on immunisation brought by the Decade of Vaccines and the draft Global Vaccine Action Plan. All children should have access to life-saving vaccines.
Last updated 25 May 2012
Thanks Mr. Chairman. I am speaking on behalf of Médecins Sans Frontières International. MSF is an independent medical humanitarian organisation that works in over 65 countries around the world.
Last updated 23 May 2012
WHA 65: MSF Intervention on Consultative Expert Working Group on Research and Development: Financing and Coordination
65th World Health Assembly - agenda item 13.14 Consultative Expert Working Group on Research and Development: Financing and Coordination Intervention by Michelle Childs, Médecins Sans Frontières International 26th May 2012
7 May 2012 - Médecins Sans Frontières (MSF) believes that the EP Committee on Development's draft opinion on the proposal for a Council decision on the conclusion of the Anti-Counterfeiting Trade Agreement (ACTA) is flawed and should not be accepted in its current form. This opinion which was prepared for the Committee on International Trade has failed to address key concerns about the adverse impact of ACTA on access to medicines. Specifically, it has not addressed the following three concerns previously highlighted by MSF:
Last updated 8 May 2012
Health activists welcome High Court judgment on anti-counterfeit law 20 April 2012 -- After three years of waiting, health activists today welcomed a decision by the High court that the Kenya Anti-Counterfeit Act 2008 was vague and could undermine access to affordable generic medicines. High Court Judge Mumbi Ngugi, found that the Act had failed to clearly distinguish between counterfeit and generic medicines.
Last updated 20 April 2012
Last updated 24 February 2012